Regulation of MT1-MMP gene expression by HMGI-C

HMGI-C对MT1-MMP基因表达的调控

基本信息

  • 批准号:
    11694311
  • 负责人:
  • 金额:
    $ 9.96万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

In the present studies, we have demonstrated that proMMP-2 activation mediated by MT1-MMP is correlated with lymph node metastases of carcinoma cells in the human invasive thyroid carcinomas and oral squamous cell carcinomas. MT1-MMP was shown to be expressed in the carcinoma cells and stromal cells adjacent to the carcinoma cell nests by in situ hybridization and immunohistochemistry, and gelatinolytic activity was demonstrated in the carcinoma cell nests by in situ zymography. In human gliomas, activation of proMMP-2 was remarkably enhanced in the glioblastomas with cerebrospinal dissemination as compared with those without dissemination. This was related with enhanced expression of MT1-MMP and decreased production of TIMP-2. Correlation between the expression of MT1-MMP and HMGI-C in human gliomas is now under study. In addition to cancer tissues, we also examined MT1-MMP expression in rheumatoid synovial tissues and demonstrated the implications of MT1-MMP for the proMMP-2 activation. We developed a two-step sandwich enzyme immunoassay for MT1-MMP, by which production level in the carcinoma tissues was shown to be higher in the oral squamous cell carcinomas than in non-carcinoma tissues. In the human lung carcinomas, MT1-MMP level was significantly increased in the carcinomas with lymph node metastasis as compared with those without metastasis. Transgenic mice over-expressing MMP-1 in macrophages were crossed with ApoE-knockout mice, and those mice were fed with western high-fat diet. In contrary to our expectation, over-expression of MMP-1 resulted in improvement of atherosclerosis. Co-expression of MT1-MMP and HMGI-C was not shown in the developing or adult mice. In addition, no correlation was demonstrated in the skin tumors caused by two-step chemical carcinogenesis in mice, suggesting that HMGI-C may not be directly involved in the MT1-MMP gene expression in mice.
在本研究中,我们已经证明,由MT 1-MMP介导的proMMP-2活化与人浸润性甲状腺癌和口腔鳞状细胞癌中癌细胞的淋巴结转移相关。原位杂交和免疫组化显示MT 1-MMP在癌细胞和癌细胞巢附近的基质细胞中表达,原位酶谱显示癌细胞巢中有明胶溶解活性。在人脑胶质瘤中,proMMP-2的激活在有脑脊髓播散的胶质母细胞瘤中显著增强,与那些没有播散的胶质母细胞瘤相比。这与MT 1-MMP表达增强和TIMP-2产生减少有关。MT 1-MMP和HMGI-C在人脑胶质瘤中的表达相关性正在研究中。除癌组织外,我们还检测了MT 1-MMP在类风湿性滑膜组织中的表达,并证明了MT 1-MMP对proMMP-2激活的影响。我们建立了一种两步夹心酶联免疫法检测MT 1-MMP,结果表明,口腔鳞癌组织中MT 1-MMP的产生水平高于非癌组织。在人肺癌中,有淋巴结转移的癌组织中MT 1-MMP水平显著高于无淋巴结转移的癌组织。将在巨噬细胞中过表达MMP-1的转基因小鼠与ApoE基因敲除小鼠杂交,并以西方高脂饮食喂养这些小鼠。与我们的预期相反,MMP-1的过度表达导致动脉粥样硬化的改善。MT 1-MMP和HMGI-C的共表达在发育或成年小鼠中未显示。此外,在小鼠两步化学致癌引起的皮肤肿瘤中没有证明相关性,表明HMGI-C可能不直接参与小鼠MT 1-MMP基因表达。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakamura H.: "Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas"Cancer Res.. 59. 467-473 (1999)
Nakamura H.:“人乳头状甲状腺癌中膜型 1 基质金属蛋白酶介导的原明胶酶 A 的产生和激活增强”Cancer Res.. 59. 467-473 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakada M., Nakamura H., Ikeda E., Fujimot N., Yamashita J., Sato H., Seiki M. and Okada Y.: "Expression and tissue localization of membrane-types 1, 2, 3 matrix metalloproteinases in human astrocytic tumors"Am. J. Pathol.. 154. 417-428 (1999)
Nakada M.、Nakamura H.、Ikeda E.、Fujimot N.、Yamashita J.、Sato H.、Seiki M. 和 Okada Y.:“人类膜型 1、2、3 基质金属蛋白酶的表达和组织定位
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Harayama T.: "Shedding of membrane type matrix metalloproteinase in a human breast carcinoma cell line"Jpn.J.Cancer Res.. 90. 942-950 (1999)
Harayama T.:“人乳腺癌细胞系中膜型基质金属蛋白酶的脱落”Jpn.J.Cancer Res.. 90. 942-950 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimada T., Nakamura H., Yamashita K., Kawata R., Murakami Y., Fujimoto N., Sato H., Seiki M. and Okada Y.: "Enhanced production of progelatinase A and its activation membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implica
Shimada T.、Nakamura H.、Yamashita K.、Kawata R.、Murakami Y.、Fujimoto N.、Sato H.、Seiki M. 和 Okada Y.:“增强原明胶酶 A 及其活化膜 1 型基质的产生
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakada M.: "Exression and tissue localization of membrane-types 1,2,3 matrix metalloproteinases in human astrocytic tumors"Am.J.Pathol.. 154. 417-428 (1999)
Nakada M.:“人星形细胞肿瘤中膜型 1,2,3 基质金属蛋白酶的表达和组织定位”Am.J.Pathol.. 154. 417-428 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OKADA Yasunori其他文献

OKADA Yasunori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OKADA Yasunori', 18)}}的其他基金

Pathological study on metalloproteinases in tissue remodeling under pathological conditions
病理条件下金属蛋白酶参与组织重塑的病理学研究
  • 批准号:
    24249022
  • 财政年份:
    2012
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Study of integral transformations in hyperfunctions and differential operators of infinite order
超函数积分变换和无限阶微分算子的研究
  • 批准号:
    22540173
  • 财政年份:
    2010
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analyses and regulation of the metabolism of tissue microenvironmental factors by metalloproteinases
金属蛋白酶对组织微环境因子代谢的功能分析和调节
  • 批准号:
    19109004
  • 财政年份:
    2007
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Pathological studies on the tissue destruction by metalloproteinases
金属蛋白酶组织破坏的病理学研究
  • 批准号:
    16209015
  • 财政年份:
    2004
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Study of global solutions to Fuchsian equations and local solutions to linear PDE
Fuchsian方程全局解和线性偏微分方程局部解的研究
  • 批准号:
    15540156
  • 财政年份:
    2003
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research concerning Privacy Protection Principles about Data Transfer from EU to the United States
欧盟至美国数据传输隐私保护原则研究
  • 批准号:
    14520022
  • 财政年份:
    2002
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular Pathology of Cartilage destruction in Rheumatoid Arthritis
类风湿关节炎软骨破坏的分子病理学
  • 批准号:
    10470051
  • 财政年份:
    1998
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analyzes on ECM metabolism in transgenic and knockout mice
转基因和基因敲除小鼠 ECM 代谢分析
  • 批准号:
    08044262
  • 财政年份:
    1996
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Studies on the destruction of articular cartilage by matrix metalloproteinases
基质金属蛋白酶破坏关节软骨的研究
  • 批准号:
    07457049
  • 财政年份:
    1995
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Development of molecular targeting therapy for head and neck cancer by targeting membrane type MMP and EBV antigen
靶向膜型MMP和EBV抗原开发头颈癌分子靶向治疗
  • 批准号:
    15390514
  • 财政年份:
    2003
  • 资助金额:
    $ 9.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了